An insulin delivery system from oxidized cellulose.

Current diabetes treatments often require frequent insulin injections, which can lead to inconsistent glucose control. Prior research has shown that oxidized cellulose can serve as a biodegradable matrix for drug delivery. However, no prior work had resolved how to achieve sustained insulin release from such a matrix. This gap motivated the investigation of oxidized cellulose as a potential platform for insulin immobilization. It was already known that periodate oxidation of cellulose creates aldehyde groups suitable for covalent binding. Yet, the ability to sustain insulin release in vivo remained unexplored. The need for long-acting insulin delivery systems is well recognized in diabetes care. Previous studies focused on synthetic polymers for insulin delivery, but natural matrices like cellulose had not been fully evaluated. This paper's contribution lies in demonstrating that oxidized cellulose can maintain glucose levels in diabetic animals for extended periods.

The aim of this study was to evaluate oxidized cellulose as a matrix for insulin immobilization and sustained release. The specific problem addressed was the need for a biodegradable and biocompatible system that could provide prolonged insulin action. The motivation stemmed from the limitations of current insulin delivery methods, which often require multiple daily injections. The study focused on whether oxidized cellulose could bind insulin via a stable chemical bond. It also aimed to determine if the matrix could release insulin in a controlled manner in vivo. The researchers sought to test if this system could maintain glucose levels in diabetic rabbits for several days. The study's design was intended to validate the potential of oxidized cellulose as a drug delivery platform. The ultimate goal was to assess the feasibility of this system for diabetes management.

The researchers used periodate-oxidized cellulose as the matrix for insulin immobilization. Insulin was bound to the matrix through the formation of a Schiff's base. The binding process involved the reaction between aldehyde groups on oxidized cellulose and amino groups on insulin. The release profile was tested in both in vitro and in vivo conditions. In vitro experiments measured insulin release in controlled environments. In vivo tests were conducted on diabetized rabbits to assess glucose regulation. The matrix was modified by reducing the Schiff's base with sodium borohydride to extend the release duration. The insulin depots were prepared as injectable suspensions for in vivo administration.

Insulin was successfully immobilized on the oxidized cellulose matrix via a Schiff's base. The release of insulin occurred through hydrolysis of the bond and matrix degradation. Reducing the Schiff's base with sodium borohydride prolonged the release duration. The in vitro release showed a sustained pattern over several days. In vivo tests demonstrated that the insulin depots maintained glucose levels in diabetic rabbits at normal values. The system provided glucose regulation for multiple days after a single injection. The insulin suspension was injectable and well-tolerated in the animal model. These findings suggest the potential of oxidized cellulose as a drug delivery system.

The authors concluded that oxidized cellulose can serve as a biocompatible matrix for insulin immobilization. The system demonstrated sustained insulin release through hydrolysis and matrix degradation. The use of sodium borohydride reduced the Schiff's base, extending the release period. The in vivo results showed that the depots could regulate glucose levels in diabetic rabbits for several days. The injectable suspension format was convenient for administration. The findings suggest that this system could be suitable for prolonged insulin delivery. The study supports the potential of oxidized cellulose as a drug delivery platform. Further research may explore the application of this system in human diabetes management.